Robert Locastro, DPM
Podiatrist · Hauppauge, NYNPI 1982606323
Payments from drug & device makers
Across 34 payments — averaging $109.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$664
- Stryker$615
- Organogenesis Inc.$396
- Smith+Nephew$332
- Paratek Pharmaceuticals, Inc.$242
- Acera Surgical, Inc.$181
- plus $1K from 12 others
What the payments were for
- Food & beverage$3,720100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 5 | $664 |
| Stryker | 5 | $615 |
| Organogenesis Inc. | 3 | $396 |
| Smith+Nephew | 6 | $332 |
| Paratek Pharmaceuticals, Inc. | 2 | $242 |
| Acera Surgical, Inc. | 1 | $181 |
| Next Science LLC | 1 | $145 |
| SPR Therapeutics, Inc | 1 | $141 |
| Advanced Oxygen Therapy Inc. | 1 | $140 |
| Lifenet Health | 1 | $140 |
| Linvatec Corporation | 1 | $137 |
| ANI Pharmaceuticals, Inc. | 1 | $125 |
| Abbott | 1 | $125 |
| Amgen | 1 | $111 |
| Extremity Medical | 1 | $106 |
| Orthofix Medical, Inc. | 1 | $84 |
| Integra Lifesciences Corporation | 1 | $23 |
| Averitas Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HOFFMANN$404
- DALVANCE$388
- NUZYRA$242
- Restrata Wound Matrix$181
- PuraPly$166
- AUGMENT INJECTABLE$161
- GRAFIX PL$150
- ACTICOAT 4" X 4"$148
- ALLEVYN HEEL 10.5CM X 13.5CM CTN 5$148
- Iodosorb Ointment 40g USA$148
- COLLAGENASE SANTYL$148
- SurgX$145
- Xperience$145
- BlastX$145
- SPRINT PNS System$141
- Topical oxygen chamber for extremities$140
- TheraGenesis Wound Matrix$140
- LINVATEC EXTREMITIES$137
- Diamondback Peripheral$125
- PURIFIED CORTROPHIN GEL$125
How this compares
$3,720 in reported general payments places this provider in the 85th percentile of 862 podiatrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxepin Hcl | 455 | $48,871 |
| Diclofenac Sodium ErDiclofenac Sodium | 581 | $44,707 |
| Fluocinonide | 406 | $31,940 |
| Clotrimazole | 258 | $15,297 |
| Ammonium Lactate | 232 | $5,254 |
| Fluconazole | 38 | $4,904 |
| Etodolac | 37 | $4,078 |
| CiclopiroxCiclopirox Olamine | 71 | $2,798 |
| Naproxen Sodium | 14 | $1,156 |
| Ketoconazole | 15 | $534 |
| Mupirocin | 25 | $149 |
| Sulindac | 18 | $108 |
| Terbinafine Hcl | 20 | $91 |
| Nabumetone | 20 | $55 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Hauppauge
- Christopher BromleyPoughkeepsie$152K
- Scott GawlikBrooklyn$77K
- Waldemar MajdanskiAstoria$71K
- Michael HutzelSeaford$64K
- Donald RubinCorning$53K
- Steven NormanMiddle Village$42K
- Elvis DanneNew York$35K
- Adam CirlincioneGlen Cove$31K
- Jude ViolanteNiagara Falls$30K
- Ammar Al RubaiayNew Hyde Park$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.